Krafft U - Search Results

1

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer.

Olah C, Reis H, Hoffmann MJ, Mairinger F, Ting S, Hadaschik B, Krafft U, Grünwald V, Nyirady P, Varadi M, Győrffy B, Kiss A, Szekely E, Sjödahl G, Szarvas T. Olah C, et al. Among authors: krafft u. Cancer Med. 2023 Mar;12(5):5222-5232. doi: 10.1002/cam4.5324. Epub 2022 Oct 7. Cancer Med. 2023. PMID: 36204983 Free PMC article.

2

Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.

Thiem S, Herold T, Krafft U, Bremmer F, Tolkach Y, Szász AM, Kriegsmann J, Gaisa NT, Niedworok C, Szarvas T, Reis H. Thiem S, et al. Among authors: krafft u. Pathol Int. 2017 Dec;67(12):597-601. doi: 10.1111/pin.12594. Epub 2017 Oct 19. Pathol Int. 2017. PMID: 29047227

3

Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Reis H, Krafft U, Niedworok C, Módos O, Herold T, Behrendt M, Al-Ahmadie H, Hadaschik B, Nyirady P, Szarvas T. Reis H, et al. Among authors: krafft u. Dis Markers. 2018 Mar 12;2018:7308168. doi: 10.1155/2018/7308168. eCollection 2018. Dis Markers. 2018. PMID: 29721106 Free PMC article. Review.

4

The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer.

Darr C, Krafft U, Hadaschik B, Tschirdewahn S, Sevcenco S, Csizmarik A, Nyirady P, Küronya Z, Reis H, Maj-Hes A, Shariat SF, Kramer G, Szarvas T. Darr C, et al. Among authors: krafft u. Urol Int. 2018;101(1):65-73. doi: 10.1159/000489891. Epub 2018 Jun 27. Urol Int. 2018. PMID: 29949801

5

Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer.

Krafft U, Reis H, Ingenwerth M, Kovalszky I, Becker M, Niedworok C, Darr C, Nyirády P, Hadaschik B, Szarvas T. Krafft U, et al. Pathol Oncol Res. 2020 Jan;26(1):253-261. doi: 10.1007/s12253-018-0447-z. Epub 2018 Jul 17. Pathol Oncol Res. 2020. PMID: 30019121 Free article.

6

Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.

Krafft U, Tschirdewahn S, Hess J, Harke NN, Hadaschik B, Olah C, Krege S, Nyirády P, Szendröi A, Szücs M, Módos O, Székely E, Reis H, Szarvas T. Krafft U, et al. Urol Oncol. 2019 Nov;37(11):810.e7-810.e15. doi: 10.1016/j.urolonc.2019.04.015. Epub 2019 Apr 30. Urol Oncol. 2019. PMID: 31053526

7

STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.

Krafft U, Tschirdewahn S, Hess J, Harke NN, Hadaschik BA, Nyirády P, Szendröi A, Szücs M, Módos O, Olah C, Székely E, Reis H, Szarvas T. Krafft U, et al. Pathol Oncol Res. 2020 Apr;26(2):1243-1249. doi: 10.1007/s12253-019-00689-y. Epub 2019 Jun 27. Pathol Oncol Res. 2020. PMID: 31250373 Free article.

8

Renal duplication with ureter duplex not following Meyer-Weigert-Rule with development of a megaureter of the lower ureteral segment due to distal stenosis - A case report.

Darr C, Krafft U, Panic A, Tschirdewahn S, Hadaschik BA, Rehme C. Darr C, et al. Among authors: krafft u. Urol Case Rep. 2019 Nov 14;28:101038. doi: 10.1016/j.eucr.2019.101038. eCollection 2020 Jan. Urol Case Rep. 2019. PMID: 31763165 Free PMC article.

9

First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11.

Darr C, Krafft U, Fendler WP, Costa PF, Barbato F, Praus C, Reis H, Hager T, Tschirdewahn S, Radtke JP, Herrmann K, Hadaschik BA. Darr C, et al. Among authors: krafft u. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3194-3195. doi: 10.1007/s00259-020-04778-y. Epub 2020 Apr 30. Eur J Nucl Med Mol Imaging. 2020. PMID: 32356006 No abstract available.

10

Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy-A Feasibility Study.

Darr C, Finis F, Wiesenfarth M, Giganti F, Tschirdewahn S, Krafft U, Kesch C, Bonekamp D, Forsting M, Wetter A, Reis H, Hadaschik BA, Haubold J, Radtke JP. Darr C, et al. Among authors: krafft u. Eur Urol Oncol. 2022 Jun;5(3):357-361. doi: 10.1016/j.euo.2020.08.004. Epub 2020 Aug 29. Eur Urol Oncol. 2022. PMID: 32873530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page